UCHL5 and leukemia: This study demonstrated that the USP14/UCHL5 inhibitors b-AP15 and AUR effectively inhibited the K48-mediated deubiquitination of ubiquitin bound to FLT3 in leukemia cells with FLT3-ITD mutations.